Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

StemCells, Adventrx guide drug stocks south
Marketwatch
Friday, January 7, 2011 - 10:53am
tags:
StemCells, Adventrx, drug stocks
StemCells gets $10M stock financing
Bizjournals.com
Friday, January 7, 2011 - 10:35am
tags:
financing, StemCells, stock offering
Savient Reports Batch Failures With New Gout Medicine
Bloomberg
Friday, January 7, 2011 - 10:34am
tags:
Savient, gout, Krystexxa
Pfizer, Sutro cut peptide drug deal
Bizjournals.com
Friday, January 7, 2011 - 10:33am
tags:
Pfizer, Sutro, peptides
AstraZeneca: FDA Extends Vandetanib NDA Review Timeline To April 7
WSJ Online
Friday, January 7, 2011 - 10:07am
tags:
FDA, NDA, vandetanib, AstraZeneca
Amgen licenses Xencor's early-stage autoimmune drug
Fierce Biotech
Friday, January 7, 2011 - 10:04am
tags:
Amgen, Xencor, autoimmune disease
Avastin Decision Not Based On Cost: FDA Official
Pharmalot
Friday, January 7, 2011 - 9:59am
tags:
Avastin, FDA, breast cancer, Roche
Dendreon Bringing Provenge to Europe
TheStreet.com
Friday, January 7, 2011 - 9:57am
tags:
Provenge, Europe, Dendreon, vaccines, prostate cancer
Novartis sight drug gets broader EU approval
Reuters
Friday, January 7, 2011 - 9:42am
tags:
Novartis, Lucentis, Europe
Pfizer Sues Novartis’ Sandoz Unit Over Vfend Antifungal Drug
Bloomberg
Friday, January 7, 2011 - 9:41am
tags:
Pfizer, generics, antifungals, Vfend, Sandoz, lawsuits
Symphogen lines up record $131M venture round
Fierce Biotech
Friday, January 7, 2011 - 7:24am
tags:
Symphogen, venture capital
19 Steps To A More Transparent FDA?
Pharmalot
Friday, January 7, 2011 - 7:22am
tags:
FDA
Lasting District Sales Manager Advice for his Pharmaceutical Sales Representative
Pharmareform
Friday, January 7, 2011 - 7:21am
tags:
drug reps
Biotech Stock Mailbag: Best Stocks to Watch in '11
TheStreet.com
Friday, January 7, 2011 - 7:21am
tags:
Oncothyreon, Xoma, Amarin, Opexa, Human Genome, Seattle Genetics, Vertex Pharmaceuticals, Merck, Dendreon, Biogen Idec, Amgen, Pharmasset
Lexicon Pharma shares soar after study reported
Yahoo/AP
Friday, January 7, 2011 - 7:18am
tags:
Lexicon Pharmaceuticals, diabetes, LX4211
Amarin Shares Popped: What You Need to Know
Motley Fool
Thursday, January 6, 2011 - 4:26pm
tags:
Amarin
Bristol-Myers should beat rivals after 2015 -CEO
Reuters
Thursday, January 6, 2011 - 1:19pm
tags:
Pharma CEOs, Bristol-Myers Squibb, Lamberto Andreotti
Wall Street Wants To Bet On Pharma Whistleblowers
Pharmalot
Thursday, January 6, 2011 - 1:18pm
tags:
whistleblowers, Wall Street
Yet Another Group Sues Medicare Over Provenge
Pharmalot
Thursday, January 6, 2011 - 1:16pm
tags:
Medicare, Provenge, Dendreon, prostate cancer
Isis Pharma adds cancer, obesity drugs to pipeline
Yahoo/AP
Thursday, January 6, 2011 - 1:15pm
tags:
cancer, Isis Pharmaceuticals, obesity

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.